Infection in the neutropenic and stem cell transplant patient

被引：1

作者：

Klastersky, J ^{[1
]}

机构：

[1] Free Univ Brussels, Inst Jules Bordet, Ctr Tumeurs, Med Serv, B-1000 Brussels, Belgium

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1999年 / 12卷 / 04期

关键词：

D O I：

10.1097/00001432-199908000-00008

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The spectrum of infectious complications in neutropenic patients after stem cell or bone marrow transplant is not very different from that seen in other neutropenic patients, with the possible exception of fungal infections. The prevention and therapy of these infections remain a major challenge. The management of neutropenic patients after stem cell or bone marrow transplant has markedly benefited from the development of new antiviral agents and the use of granulocyte/macrophage colony stimulating factors. (C) 1999 Lippincott Williams & Wilkins.

引用

页码：355 / 358

页数：4

共 32 条

[1] Predictors of adverse outcome in cancer patients with candidemia [J].

Anaissie, EJ ;

Rex, JH ;

Uzun, Ö ;

Vartivarian, S .

AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) :238-245

[2] Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation [J].

Bilgrami, S ;

Feingold, JM ;

Dorsky, D ;

Edwards, RL ;

Clive, J ;

Tutschka, PJ .

BONE MARROW TRANSPLANTATION, 1998, 21 (06) :591-595

[3]

Bowden Raleigh A., 1997, American Journal of Medicine, V102, P27, DOI 10.1016/S0002-9343(97)00007-7

[4] Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients - A 5-year prospective study [J].

Elishoov, H ;

Or, R ;

Strauss, N ;

Engelhard, D .

MEDICINE, 1998, 77 (02) :83-101

[5] An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis [J].

Ellis, M ;

Spence, D ;

de Pauw, B ;

Meunier, F ;

Marinus, A ;

Collette, L ;

Sylvester, R ;

Meis, J ;

Boogaerts, M ;

Selleslag, D ;

Kremery, V ;

von Sinner, W ;

MacDonald, P ;

Doyen, C ;

Vandercam, B .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1406-1412

[6] Early infection in bone marrow transplantation: Quantitative study of clinical factors that affect risk [J].

Engels, EA ;

Ellis, CA ;

Supran, SE ;

Schmid, CH ;

Barza, M ;

Schenkein, DP ;

Koc, Y ;

Miller, KB ;

Wong, JB .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :256-266

[7] Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis [J].

Engels, EA ;

Lau, J ;

Barza, M .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1179-1187

[8] Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants [J].

Giles, FJ .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) :1282-1289

[9] Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease [J].

Gor, D ;

Sabin, C ;

Prentice, HG ;

Vyas, N ;

Man, S ;

Griffiths, PD ;

Emery, VC .

BONE MARROW TRANSPLANTATION, 1998, 21 (06) :597-605

[10] Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients [J].

Hess, U ;

Bohme, C ;

Rey, K ;

Senn, HJ .

SUPPORTIVE CARE IN CANCER, 1998, 6 (04) :402-409

← 1 2 3 4 →